期刊文献+

Decorin mRNA和p57^(KIP2) mRNA在非小细胞肺癌中的表达及其临床意义 被引量:2

Study on expression of Decorin mRNA and p57^(KIP2) mRNA and their clinical significance in non-small cell lung cancer
下载PDF
导出
摘要 目的检测Decorin mRNA和p57^(KIP2) mRNA在非小细胞肺癌中的表达情况,并分析它们与非小细胞肺癌的病理、临床特征及预后的关系。方法选取石蜡包埋的59例非小细胞肺癌及12例癌旁正常肺组织的标本制作组织芯片。利用原位杂交法检测Decorin mRNA和p57^(KIP2) mRNA的表达情况。结果Decorin mRNA在癌旁正常肺组织和非小细胞肺癌组织中的表达率分别为66.7%(8/12)和20.3%(12/59),正常组织中Decorin mRNA的表达高于肺癌组织(P<0.05)。大细胞肺癌中Decorin mRNA的表达高于鳞癌(P<0.05)。鳞癌中p57^(KIP2) mRNA的阳性表达率为63.2%(12/19),高于腺癌、大细胞癌和小细胞癌(P<0.05)。在无淋巴结转移的非小细胞肺癌标本中Decorin mRNA和p57^(KIP2) mRNA的表达呈增高趋势,与有淋巴结转移的标本比较其差异具有统计学意义。Decorin mRNA和p57^(KIP2) mRNA的表达无相关性(P>0.05)。结论Decorin和p57^(KIP2)的表达可能与非小细胞肺癌的组织学类型和转移有关,有望成为监测非小细胞肺癌患者病情发展及评价预后的有用指标。 Objective:To investigate the expression of Decorin mRNA and p57^KIP2 mRNA and analyze their relationship with pathogenesis and clinical characteristics in non-small cell lung cancer. Methods:Paraffin-embedded tissues from 59 cases of non-small cell lung cancer and 12 cases of normal lung tissues adjacent to tumor tissues were selected to make tissue chip, and expression of Decorin mRNA and p57^KIP2 mRNA were examined by in situ hybridization using labelled digoxigenin probes. Results:The expression rates of Decorin mRNA were 20. 3% (12/59) in tumor tissues and 66, 7% (8/12) in normal tissues, The normal tissues showed a higher expression of Decorin mRNA than that of the tumor tissues ( P 〈 0. 05 ). The expression rate of Decorin mRNA was higher in large cell lung adenocarcinoma(LCLC) than that of squamous cell carcinoma of the lung( LSCC), The positive expression rates were 5.3% ( 1/19), 50% (4/4) respectively(P 〈0. 05). The expression rate of p57^KIP2 mRNA in LSCC was 63. 2% ( 12/19), being higher than adenocarcinoma of the lung(LAC), LCLC and alveolar carcinoma (P 〈0. 05). In non-small cell lung cancer without lymph node metastasis, The expression of Decorin mRNA and p57^KIP2 mRNA was increased significantly( P 〈 0. 05 ). However there was no correlation between Decorin mRNA and p57^KIP2 mRNA. Conclusion: These results suggest that Decorin gene and p57^KIP2 gene closely relate to the non-small cell lung cancer metastasis and histological classification. The two genes may be an index in monitoring the status and evaluating the prognosis of the non-small cell lung cancer.
出处 《临床肿瘤学杂志》 CAS 2006年第5期331-335,共5页 Chinese Clinical Oncology
关键词 非小细胞肺癌 DECORIN MRNA P57^KIP2 组织芯片 原位杂交 Non-small cell lung cancer Decorin mRNA p57^KIP2 mRNA Tissue microarray In situ hybridization
  • 相关文献

参考文献6

  • 1Matsumoto M,Farihata M,Ohtsuki Y,et al.Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma[J].Anticancer Res,2000,20(3B):1947-1952.
  • 2Marko S,Ulrike N,Wolfgang W,et al.Transforming growth factor-β and P-21:multiple molecular targets of decorin-mediated suppression of euplastic growdth[J].Cell Tissue Res,1999,296:221-227.
  • 3Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high-throughout molecular profilling of tumor specimens[J].Nature Med,1998,4(7):844-847.
  • 4Reed C,Waterhouse A,Kirby S,et al.Decorin preverts mestatic spread of breast cancer[J].Oncogene,2005,24(6):1104-1110.
  • 5Grant DS,Yenisey C,Rose RW,et al.Decorin suppresses tumor cell-mediated angiogensis[J].Oncogene,2002,21(31):4765-4777.
  • 6Lee MP,Debaun M,Randhawa G,et al.Low frequency of p57KIP2 mutation in BECK with-Wiedemann syndrome[J].Am J Hum Genet,1997,61:304-309.

同被引文献15

  • 1操海萍,舒振波,张桂珍.核心蛋白聚糖mRNA及其蛋白在结直肠癌中的表达[J].吉林大学学报(医学版),2006,32(2):316-318. 被引量:4
  • 2Fisher LW, Termine JD, Young MF. Deduced protein se- ctuence of bone small proteoglycan I (biglycan) shows ho- mology with proteoglycan II (decorin) and several noneon nective tissue proteins in a variety of species. J Biol Chem, 1989,264(8):4571- 4576.
  • 3Goldoni S, Owens RT, McQuillan DJ, et al. Biologically ac- tive decorin is a monomer in solution. J Biol Chem, 2004, 279(8) ..6606-6612.
  • 4Jarvelainen H,Vernon RB,Gooden MD, et al. Overexpres- sion of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro. Arterioscler Thromb Vasc Biol,2004,24(1) :67- 72.
  • 5McDoniels-Silvers AL, Nimri CF, Stoner GD, et al. Differ ential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res, 2002, 8 ( 4 ) : 1127 -1138.
  • 6Matsumine A, Shintani K, Kusuzaki K, et al. Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Oncol,2007,96(5) :411- 418.
  • 7Koninger J, Giese NA, di Mola FF, et al. Overexpressed decorin in pancreatic cancer: potential tumor growth inhi- bition and attenuation of chemotherapeutic action. Clin Cancer Res, 2004,10 (14) : 4776-4783.
  • 8Goldoni S, Seidler DG, Heath J, et al. An antimetastatic role for deeorin in breast cancer. Am J Pathol, 2008,173 (3): 844-855.
  • 9Nash MA,Loercher AE,Freedman RS. In vitro growth in- hibition of ovarian cancer cells by decorin: synergism of ac- tion between decorin and carboplatin. Cancer Res, 1999,59(24):6192-6196.
  • 10Andrade W, Brandan E. Isolation and characterization of rat skeletal muscle proteoglycan decorin and comparison with the human fibroblast decorin. Comp Biochem Physiol B,1991,100(3) :565-570.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部